Literature DB >> 19040491

Heterogeneous molecular background of the weak C, VS+, hr B-, Hr B- phenotype in black persons.

Bach-Nga Pham1, Thierry Peyrard, Genevieve Juszczak, Isabelle Dubeaux, Dominique Gien, Antoine Blancher, Jean-Pierre Cartron, Philippe Rouger, Pierre-Yves Le Pennec.   

Abstract

BACKGROUND: The rare Hr(B)- phenotype is encoded by the (C)ce(s) haplotype when present at the homozygous state. This haplotype contains two altered genes: a hybrid RHD-CE-D(s) gene segregated with a ce(s) allele of RHCE (733C>G and 1006G>T substitutions in Exon 5 and Exon 7 respectively). The aim of this study was to further investigate the molecular background of the (C)ce(s) haplotype. STUDY DESIGN AND METHODS: Twelve individuals with depressed C and/or depressed e phenotype were selected from their genomic DNA analysis showing both 733C>G and 1006G>T substitutions. Phenotypic expression of low- and high-prevalence Rh antigens was studied. Complete sequences of RHD and RHCE transcripts were analyzed when obtained.
RESULTS: A new hybrid RHD-CE-D(s) gene (Exons 1 and 2; complete Exon 3; Exons 8, 9, and 10 from RHD; and Exons 4 through 7 from RHCE) segregated with a ce(s) allele, which genomic organization was almost identical to that of the classical (C)ce(s) haplotype, is described. The two different (C)ce(s) haplotypes encoded two different patterns of Rh antigen expression. Although both encoded weak e, VS, and did not produce D, V, hr(B), or Hr(B) antigens, the new haplotype encoded a much weaker C antigen and red blood cells lacked expression of Rh42, in contrast to the classic (C)ce(s) haplotype.
CONCLUSION: The study showed the heterogeneity of the molecular background of the weak C, VS+, hr(B)-, Hr(B)- phenotype in the black population. The screening of blood donors in this population for hr(B)- or Hr(B)- phenotype should implement the molecular characterization of Rh genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040491     DOI: 10.1111/j.1537-2995.2008.02005.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  10 in total

1.  Two molecular polymorphisms to detect the (C)ce(s) type 1 haplotype.

Authors:  Willy A Flegel; Franz F Wagner
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

2.  Transfusion considerations concerning patients with anti-hrB and confounding co-morbid conditions: pregnancy and coagulopathy.

Authors:  Natasha M Savage; Wadicar F Nugent; Lawrence D Devoe; Roni J Bollag; Lloyd O Cook
Journal:  Blood Transfus       Date:  2010-12-27       Impact factor: 3.443

3.  (C)ce(s) haplotype screening in Tunisian blood donors.

Authors:  Hajer Moussa; Néjiba Ghommen; Houda Romdhane; Saadia Abdelkefi; Taher Chakroun; Batoul Houissa; Saloua Yacoub Jemni
Journal:  Blood Transfus       Date:  2013-12-04       Impact factor: 3.443

Review 4.  DNA-based methods in the immunohematology reference laboratory.

Authors:  Marion E Reid; Gregory A Denomme
Journal:  Transfus Apher Sci       Date:  2011-01-22       Impact factor: 1.764

Review 5.  Five-Years Review of RHCE Alleles Detected after Weak and/or Discrepant C Results in Southern France.

Authors:  Pascal Pedini; Lugdivine Filosa; Nelly Bichel; Christophe Picard; Monique Silvy; Jacques Chiaroni; Caroline Izard; Laurine Laget; Stéphane Mazières
Journal:  Genes (Basel)       Date:  2022-06-14       Impact factor: 4.141

6.  DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications.

Authors:  Connie M Westhoff; Sunitha Vege; Christine Halter-Hipsky; Trina Whorley; Kim Hue-Roye; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2010-01-15       Impact factor: 3.157

7.  A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data.

Authors:  Ti-Cheng Chang; Kelly M Haupfear; Jing Yu; Evadnie Rampersaud; Vivien A Sheehan; Jonathan M Flanagan; Jane S Hankins; Mitchell J Weiss; Gang Wu; Sunitha Vege; Connie M Westhoff; Stella T Chou; Yan Zheng
Journal:  Blood Adv       Date:  2020-09-22

8.  D category IV: a group of clinically relevant and phylogenetically diverse partial D.

Authors:  Inge von Zabern; Franz F Wagner; Joann M Moulds; John J Moulds; Willy A Flegel
Journal:  Transfusion       Date:  2013-03-05       Impact factor: 3.157

Review 9.  The molecular genetics of blood group polymorphism.

Authors:  Geoff Daniels
Journal:  Hum Genet       Date:  2009-08-29       Impact factor: 4.132

10.  Molecular Blood Group Screening in Donors from Arabian Countries and Iran Using High-Throughput MALDI-TOF Mass Spectrometry and PCR-SSP.

Authors:  Brigitte Katharina Flesch; Vanessa Scherer; Burkhard Just; Andreas Opitz; Oswin Ochmann; Anne Janson; Monika Steitz; Thomas Zeiler
Journal:  Transfus Med Hemother       Date:  2020-01-22       Impact factor: 3.747

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.